Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Events Archives
Print | Email | Share | Comments (0)

Clinical Trial Aims to Lower Insulin Requirements


Jun 1, 1997

Ergo Science Corporation, located in Charlestown, Massachusetts, has initiated a human clinical trial for FDA approval of its Ergoset tablets. The tablets are intended to reduce insulin requirements for people with type 2 diabetes who are on insulin.

The object of the trial is to lower BGs and daily insulin requirements of people with type 2 whose BGs have not been sufficiently controlled on oral hypoglycemic agents and insulin. This type of patient represents approximately three million of the seven million type 2s who receive treatment for their diabetes.

Efficient use of insulin for these patients is important as excess insulin in the bloodstream has been associated with cardiovascular disease.

The phase III human clinical trial of Ergoset for FDA approval demonstrated "significant and meaningful results in people with type 2 diabetes," according to a company press release.


Categories: Diabetes, Events, Insulin, Type 1 Issues, Type 2 Issues



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.